Exocrine Pancreatic Insufficiency (EPI) Market

• steve Smith
• Health
• November 27, 2024

Exocrine Pancreatic Insufficiency (EPI) Market Set to Experience a Massive 7.2% CAGR During 2024-2030

In 2023, First Wave BioPharma, Inc., announced the initiation of its planned Phase 2 clinical…